News from NORD

NORD and Neurology Reviews Publish Special Report


 

NORD and Neurology Reviews together have published the third annual Rare Neurological Disease Special Report in print and digital editions to promote awareness and understanding of rare neurological diseases among medical professionals. The publication includes articles on the efficacy of cannabis in treating children with rare and refractory epilepsy, delays in diagnosis and treatment of infantile spasms, telemedicine, new and potential therapies for rare neuromuscular disorders, and the clinical therapeutic potential of gene therapy.

Recommended Reading

Foundation for Prader-Willi Research Highlights Study of Genetic Therapy for Prader-Willi Syndrome
MDedge Hematology and Oncology
Guidelines tackle long-term screening, management of myeloma
MDedge Hematology and Oncology
GAO to launch investigation of FDA’s Orphan Drug program
MDedge Hematology and Oncology
NORD Awards Grants for Rare Disease Research
MDedge Hematology and Oncology
NORD Publishes Basic Principles for Health Coverage Reform
MDedge Hematology and Oncology
NORD Submits Letter to Congress on Pre-Existing Conditions
MDedge Hematology and Oncology
NORD Unveils “Do Your Share for Rare” Year-Long Awareness Campaign
MDedge Hematology and Oncology
Tickets Now On Sale for NORD’s 2017 Rare Impact Awards
MDedge Hematology and Oncology
Safety of N9-GP for hemophilia B needs further study, FDA committee agrees
MDedge Hematology and Oncology
NORD Announces Recipients of 2017 Rare Impact Awards
MDedge Hematology and Oncology